Docoh
Loading...

39 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
INFORMATION Purpose of the Meeting About the Annual Meeting PROPOSAL NO. 1 ELECTION OF DIRECTORS CORPORATE GOVERNANCE EXECUTIVE COMPENSATION PROPOSAL NO. 2 … Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission as well as our corporate governance and other related
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
governance and strategy. Geraldine Liu Pannu – Ms. Pannu has served as a Director since February 13, 2020. Ms. Pannu has over 25 years of experience … , each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee members
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
governance; creating a disclosure committee; expanding review and monitoring procedures; and improving documentation of our policies and procedures
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
of a listed company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also … and corporate governance committee satisfy the independence standards for such committees established by the SEC and the Nasdaq Marketplace Rules
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange … serve on our audit committee, our compensation committee, and our nominating and corporate governance committee satisfy the independence standards
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange … serve on our audit committee, our compensation committee, and our nominating and corporate governance committee satisfy the independence standards
S-1/A
EX-3.2
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
of the corporation, and will comply with, all applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading
S-1/A
EX-10.11
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
TABLE OF CONTENTS ARTICLE I DEFINITIONS ARTICLE II GRANTS OF RIGHTS ARTICLE III DEVELOPMENT & GOVERNANCE ARTICLE IV SUPPLY ARTICLE V … ) know-how related to the Development of the Product, and (c) Regulatory Approvals or clearances or submissions. ARTICLE III DEVELOPMENT & Governance 3.1
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
TABLE OF CONTENTS ARTICLE I DEFINITIONS ARTICLE II GRANTS OF RIGHTS ARTICLE III DEVELOPMENT & GOVERNANCE ARTICLE IV SUPPLY ARTICLE V … -how related to the Development of the Product, and (c) Regulatory Approvals or clearances or submissions. ARTICLE III DEVELOPMENT & Governance 3.1
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence … governance committee satisfy the independence standards for such committees established by the SEC and the Nasdaq Marketplace Rules, as applicable. In making
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
member of a listed company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also … nominating and corporate governance committee satisfy the independence standards for such committees established by the SEC and the Nasdaq Marketplace
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent and that audit … nominating and corporate governance committee following this offering, satisfy the independence standards for such committees established by the SEC
DEF 14A
PCSA Processa Pharmaceuticals Inc
26 Apr 19
Definitive proxy
5:02pm
REGISTERED PUBLIC ACCOUNTING FIRM CORPORATE GOVERNANCE QUALIFICATIONS OF CANDIDATES FOR ELECTION TO THE BOARD BOARD OF DIRECTORS VACANCIES BENEFICIAL … to the stockholders for ratification as a matter of good corporate governance. If the appointment of BD & Company is not ratified by the stockholders
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
committee or any other form of corporate governance committee, stockholders will have to rely on our directors, a majority of which are not independent … , to perform these functions. We currently do not have an audit committee, compensation committee or any form of corporate governance committees
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
committee or any other form of corporate governance committee, stockholders will have to rely on our directors, a majority of which are not independent … , to perform these functions. We currently do not have an audit committee, compensation committee or any form of corporate governance committees
424B3
PCSA Processa Pharmaceuticals Inc
13 Nov 18
Prospectus supplement
9:39pm
committee, compensation committee or any other form of corporate governance committee, stockholders will have to rely on our directors, a majority … governance committees. The Board, a majority of which is not independent, performs these functions as a whole. Our Board is in the process of establishing
10-Q
2018 Q3
PCSA Processa Pharmaceuticals Inc
13 Nov 18
Quarterly report
9:37pm
committee, compensation committee or any other form of corporate governance committee, stockholders will have to rely on our directors, a majority … governance committees. The Board, a majority of which is not independent, performs these functions as a whole. Our Board is in the process of establishing
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
personnel. Because we do not currently have an audit committee, compensation committee or any other form of corporate governance committee … committee, compensation committee or any form of corporate governance committees. The Board, a majority of which is not independent, performs
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
of corporate governance committee, stockholders will have to rely on our directors, a majority of which are not independent, to perform these functions … . We currently do not have an audit committee, compensation committee or any form of corporate governance committees. The Board, a majority of which
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
we do not currently have an audit committee, compensation committee or any other form of corporate governance committee, stockholders will have to rely … committee or any form of corporate governance committees. The Board, a majority of which is not independent, performs these functions as a whole. Our